News
Getting a larger share of a business that you like is always something that you would take a look at,” he said. “We have ...
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...
About Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule ... aureus (MRSA), vancomycin resistant ...
aureus resistant to vancomycin—the antibiotic of last resort ... As Stuart Levy, professor of medicine, molecular biology, and microbiology at Tufts University School of Medicine (Boston ...
Purpose: The chemical interactions that cause drug incompatibility ... when daptomycin was infused after flushing and infusing vancomycin sulfate (personal communication, contact not recorded ...
Cells have a mailing system of sorts. They can release tiny molecular balls, called extracellular vesicles (EVs), that ...
Mirkin, who coauthored the paper. "In the small molecule era, it was critical to control the placement of every atom and ...
Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world's deadliest pathogen. This labeling could lead to simpler, faster TB tests.
Remedium Lifecare Limited has announced the strategic objectives of its upcoming rights issue, recently approved by the ...
Background IBD is a chronic inflammatory condition driven by complex genetic and immune interactions, yet preclinical models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results